Expression and activity of PARP family members in the hippocampus during systemic inflammation: Their role in the regulation of prooxidative genes

Neurochemistry International

Volumn 62, Issue 5, 2013, Pages 664-673

  Czapski, Grzegorz A ^a   Adamczyk, Agata ^a   Strosznajder, Robert P ^b   Strosznajder, Joanna B ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Inflammatory reaction; Neuroinflammation; Oxidative stress; Poly(ADP ribose)polymerase; Systemic inflammation

Indexed keywords

3 AMINOBENZAMIDE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; ENZYME SUBUNIT; GENE; GENE EXPRESSION; GENETIC REGULATION; HIPPOCAMPUS; INFLAMMATION; MALE; MOUSE; NONHUMAN; POLY(ADP RIBOSE)POLYMERASE 12 GENE; POLY(ADP RIBOSE)POLYMERASE 14 GENE; POLY(ADP RIBOSE)POLYMERASE 3 GENE; POLY(ADP RIBOSE)POLYMERASE 9 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION;

ANIMALS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INFLAMMATION; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES;

MUS;

EID: 84875735609     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.01.020     Document Type: Article

References (76)

1. R. Abeti, A.Y. Abramov, and M.R. Duchen Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death Brain 134 2011 1658 7162
2. C.C. Alano, P. Garnier, W. Ying, Y. Higashi, T.M. Kauppinen, and R.A. Swanson NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death J. Neurosci. 30 2010 2967 2978
3. M. Altmeyer, and M.O. Hottiger Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging Aging (Albany NY) 1 2009 458 469
4. J.C. Ame, C. Spenlehauer, and G. de Murcia The PARP superfamily Bioessays 26 2004 882 893
5. D. Angelov, A. Molla, P.Y. Perche, F. Hans, J. Cote, S. Khochbin, P. Bouvet, and S. Dimitrov The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling Mol. Cell. 11 2003 1033 1041
6. T. Arimoto, and G.Y. Bing Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration Neurobiol. Dis. 12 2003 35 45
7. C. Boehler, L.R. Gauthier, O. Mortusewicz, D.S. Biard, J.-M. Saliou, A. Bresson, S. Sanglier-Cianferani, S. Smith, V. Schreiber, F. Boussin, and F. Dantzer Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression Proc. Natl. Acad. Sci. USA 108 2011 2783 2788
8. A.H. Boulares, A.J. Zoltoski, Z.A. Sherif, P. Jolly, D. Massaro, and M.E. Smulson Gene knockout or pharmacological inhibition of poly(ADP-Ribose) polymerase-1 prevents lung inflammation in a murine model of asthma Am. J. Resp. Cell Mol. Biol. 28 2003 322 329
9. H. Buss, A. Dörrie, M.L. Schmitz, R. Frank, M. Livingstone, K. Resch, and M. Kracht Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity J. Biol. Chem. 279 2004 49571 49574
10. S.H. Cho, A.K. Ahn, P. Bhargava, C.-H. Lee, C.M. Eischen, O. McGuinness, and M. Boothby Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family Proc. Natl. Acad. Sci. USA 108 2011 15972 15977
11. W. Cho, Y. Kim, D.-I. Jeoung, Y.-M. Kim, and J. Choe IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6 Mol. Immunol. 48 2011 966 972
12. J.E. Cleaver Differential toxicity of 3-aminobenzamide to wild-type and 6-thioguanine-resistant Chinese hamster cells by interference with pathways of purine biosynthesis Mutat. Res. 131 1984 123 127
13. G.A. Czapski, M. Cakala, M. Chalimoniuk, B. Gajkowska, and J.B. Strosznajder Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation J. Neurosc. Res. 85 2007 1694 1703
14. G.A. Czapski, M. Cakala, B. Gajkowska, and J.B. Strosznajder Poly(ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation Neurochem. Int. 49 2006 751 755
15. G.A. Czapski, M. Cakala, D. Kopczuk, M. Kaminska, and J.B. Strosznajder Inhibition of nitric oxide synthase prevents energy failure and oxidative damage evoked in the brain by lipopolysaccharide Pol. J. Pharmacol. 56 2004 643 646
16. G.A. Czapski, M. Cakala, D. Kopczuk, and J.B. Strosznajder Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex Neurosci. Lett. 356 2004 45 48
17. G.A. Czapski, B. Gajkowska, and J.B. Strosznajder Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus Brain Res. 1356 2010 85 94
18. R. Dantzer, R.M. Bluthe, G. Gheusi, S. Cremona, S. Laye, P. Parnet, and K.W. Kelley Molecular basis of sickness behavior Mol. Mech. Fever 856 1998 132 138
19. F. Demarchi, C. Bertoli, P. Sandy, and C. Schneider Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability J. Biol. Chem. 278 2003 39583 39590
20. C. de la Lastra, I. Villegas, and S. Sanchez-Fidalgo Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications Curr. Pharm. Des. 13 2007 933 962
21. T. Genovese, E. Mazzon, C. Muia, N.S.A. Patel, M.D. Threadgill, P. Bramanti, A. De Sarro, C. Thiemermann, and S. Cuzzocrea Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma J. Pharm. Exp. Ther. 312 2005 449 457
22. E. Gerace, T. Scartabelli, L. Formentini, E. Landucci, F. Moroni, A. Chiarugi, and D.E. Pellegrini-Giampietro Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance Eur. J. Neurosci. 36 2012 1993 2005
23. L. Geraets, H.J.J. Moonen, K. Brauers, R.W. Gottschalk, E.F.M. Wouters, A. Bast, and G.J. Hagernan Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression Eur. J. Pharmacol. 573 2007 241 248
24. S. Goldberg, L. Visochek, E. Giladi, I. Gozes, and M. Cohen-Armon PolyADP-ribosylation is required for long-term memory formation in mammals J. Neurochem. 111 2009 72 79
25. A.M. Hamby, S.W. Suh, T.M. Kauppinen, and R.A. Swanson Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion Stroke 38 2007 632 636
26. P.O. Hassa, M. Covic, S. Hasan, R. Imhof, and M.O. Hottiger The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function J. Biol. Chem. 276 2001 45588 45597
27. P.O. Hassa, and M.O. Hottiger The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappa B in inflammatory disorders Cell. Mol. Life Sci. 59 2002 1534 1553
28. P.O. Hassa, and M.O. Hottiger The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases Front. Biosci. 13 2008 3046 3082
29. S. Homburg, L. Visochek, N. Moran, F. Dantzer, E. Priel, E. Asculai, D. Schwartz, V. Rotter, N. Dekel, and M. Cohen-Armon A fast signal-induced activation of poly(ADP-ribose) polymerase: a novel downstream target of phospholipase C J. Cell Biol. 150 2000 293 307
30. E.M. Horvath, and C. Szabó Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update Drug News Perspect. 20 2007 171 181
31. K. Iwase, K. Miyanaka, A. Shimizu, A. Nagasaki, T. Gotoh, M. Mori, and M. Takiguchi Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment J. Biol. Chem. 275 2000 11929 11933
32. M. Jacewicz, G.A. Czapski, I. Katkowska, and R.P. Strosznajder Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. The effect of PARP-1 inhibitor Folia Neuropathol. 47 2009 321 328
33. P. Juszczynski, J.L. Kutok, C. Li, J. Mitra, R.C.T. Aguiar, and M.A. Shipp BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate Mol. Cell. Biol. 26 2006 5348 5359
34. G.I. Karras, G. Kustatscher, H.R. Buhecha, M.D. Allen, C. Pugieux, F. Sait, M. Bycroft, and A.G. Ladurner The macro domain is an ADP-ribose binding module EMBO J. 24 2005 1911 1920
35. D.W. Koh, T.M. Dawson, and V.L. Dawson Mediation of cell death by poly(ADP-ribose) polymerase-1 Pharmacol. Res. 52 2005 5 14
36. D.W. Koh, T.M. Dawson, and V.L. Dawson Poly(ADP-ribosyl)ation regulation of life and death in the nervous system Cell. Mol. Life Sci. 62 2005 760 768
37. W.L. Kraus Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation Curr. Opin. Cell Biol. 20 2008 294 302
38. S. Lacroix, D. Feinstein, and S. Rivest The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations Brain Pathol. 8 1998 625 640
39. C. Le Page, J. Sanceau, J.C. Drapier, and J. Wietzerbin Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation Biochem. Biophys. Res. Commun. 243 1998 451 457
40. Y. Lin, X. Tang, Y. Zhu, T. Shu, and X. Han Identification of PARP-1 as one of the transcription factors binding to the repressor element in the promoter region of COX-2 Arch. Biochem. Biophys. 505 2011 123 129
41. O. Loseva, A.-S. Jemth, H.E. Bryant, H. Schuler, L. Lehtio, T. Karlberg, and T. Helleday PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA J. Biol. Chem. 285 2010 8054 8060
42. P. Mehrotra, J.P. Riley, R. Patel, F. Li, L.E. Voss, and S. Goenka PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation J. Biol. Chem. 286 2011 1767 1776
43. K.M. Milam, and J.E. Cleaver Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes Science 223 1984 589 591
44. D. Milatovic, S. Zaja-Milatovic, K.S. Montine, P.J. Horner, and T.J. Montine Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum J. Neurochem. 87 2003 1518 1526
45. E.G. Miller Stimulation of nuclear poly (adenosine diphosphate-ribose) polymerase activity from HeLa cells by endonucleases Biochim. Biophys. Acta 395 1975 191 200
46. F. Moroni Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage Curr. Opin. Pharmacol. 8 2008 96 103
47. F. Moroni, A. Cozzi, A. Chiarugi, L. Formentini, E. Camaioni, D.E. Pellegrini-Giampietro, Y. Chen, S. Liang, M.M. Zaleska, C. Gonzales, A. Wood, and R. Pellicciari Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase Br. J. Pharmacol. 165 2012 1487 1500
48. D.A. Nusinow, I. Hernandez-Munoz, T.G. Fazzio, G.M. Shah, W.L. Kraus, and B. Panning Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome J. Biol. Chem. 282 2007 12851 12859
49. S.L. Oei, and Y. Shi Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage Biochem. Biophys. Res. Commun. 285 2001 27 31
50. F.J. Oliver, J. Ménissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, S. Muller, G. de la Rubia, J.C. Stoclet, and G. de Murcia Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice EMBO J. 18 1999 4446 4454
51. R. Olszanecki, A. Gebska, J. Jawien, A. Jakubowski, and R. Korbut Inhibition of NOS-2 induction in LPS-stimulated J774.2 cells by 1, 5-isoquinolinediol, an inhibitor of PARP J. Physiol. Pharmacol. 57 2006 109 117
52. H. Otto, P.A. Reche, F. Bazan, K. Dittmar, F. Haag, and F. Koch-Nolte In silico characterization of the family of PARP-like poly(ADP-ribosyl) transferases (pARTs) BMC Genomics 6 2005 136
53. K. Ouararhni, R. Hadj-Slimane, S. Ait-Si-Ali, P. Robin, F. Mietton, A. Harel-Bellan, S. Dimitrov, and A. Hamiche The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity Genes Dev. 20 2006 3324 3336
54. N.K. Phulwani, and T. Kielian Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation J. Neurochem. 106 2008 578 590
55. A.A. Pieper, S. Blackshaw, E.E. Clements, D.J. Brat, D.K. Krug, A.J. White, P. Pinto-Garcia, A. Favit, J.R. Conover, S.H. Snyder, and A. Verma Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission Proc. Natl. Acad. Sci. USA 97 2000 1845 1850
56. J.M. Pleschke, H.E. Kleczkowska, M. Strohm, and F.E. Althaus Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins J. Biol. Chem. 275 2000 40974 40980
57. M. Rouleau, D. McDonald, P. Gagne, M.E. Ouellet, A. Droit, J.M. Hunter, S. Dutertre, C. Prigent, M.J. Hendzel, and G.G. Poirier PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery J. Cell. Biochem. 100 2007 385 401
58. S.L. Rulten, A.E.O. Fisher, I. Robert, M.C. Zuma, M. Rouleau, L. Ju, G. Poirier, B. Reina-San-Martin, and K.W. Caldecott PARP-3 and APLF function together to accelerate nonhomologous end-joining Mol. Cell. 41 2011 33 45
59. M. Sakaue, N. Mori, M. Okazaki, M. Ishii, Y. Inagaki, Y. Iino, K. Miyahara, M. Yamamoto, T. Kumagai, S. Hara, M. Yamamoto, and K. Arishima Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture J. Neurosci. Res. 86 2008 3427 3434
60. A. Semmler, C. Frisch, T. Debeir, M. Ramanathan, T. Okulla, T. Klockgether, and M.T. Heneka Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model Exp. Neurol. 204 2007 733 740
61. A. Semmler, S. Hermann, F. Mormann, M. Weberpals, S.A. Paxian, T. Okulla, M. Schaefers, M.P. Kummer, T. Klockgether, and M.T. Heneka Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism J. Neuroinflammation 5 2008 38
62. H.M. Smith, and A.J. Grosovsky PolyADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation Carcinogenesis 20 1999 1439 1443
63. M. Songin, H. Jesko, G. Czapski, A. Adamczyk, and R.P. Strosznajder GSK-3 beta and oxidative stress in aged brain. Role of poly(ADP-ribose) polymerase-1 Folia Neuropathol. 45 2007 220 229
64. J.B. Strosznajder, G.A. Czapski, A. Adamczyk, and R.P. Strosznajder Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease Mol. Neurobiol. 46 2012 78 84
65. J.B. Strosznajder, H. Jeśko, and R.P. Strosznajder Effect of amyloid beta peptide on poly(ADP-ribose) polymerase activity in adult and aged rat hippocampus Acta Biochim. Pol. 47 2000 847 854
66. R. Strosznajder, and B. Gajkowska Effect of 3-aminobenzamide on Bcl-2, Bax and AIF localization in hippocampal neurons altered by ischemia-reperfusion injury. The immunocytochemical study Acta Neurobiol. Exp. 66 2006 15 22
67. R.P. Strosznajder, K. Czubowicz, H. Jesko, and J.B. Strosznajder Poly(ADP-Ribose) metabolism in brain and its role in ischemia pathology Mol. Neurobiol. 41 2010 187 196
68. R.P. Strosznajder, R. Gadamski, G.A. Czapski, H. Jesko, and J.B. Strosznajder Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia-its role in brain edema and cell death J. Mol. Neurosci. 20 2003 61 71
69. R.P. Strosznajder, H. Jesko, and A. Zambrzycka Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury Mol. Neurobiol. 31 2005 149 167
70. C. Szabo, and V.L. Dawson Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion Trends Pharmacol. Sci. 19 1998 287 298
71. B. Veres, F. Gallyas, G. Varbiro, Z. Berente, E. Osz, G. Szekeres, C. Szabo, and B. Sumegi Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock Biochem. Pharmacol. 65 2003 1373 1382
72. B. Veres, B. Radnai, F. Gallyas, G. Varbiro, Z. Berente, E. Osz, and B. Sumegi Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice J. Pharmacol. Exp. Ther. 310 2004 247 255
73. Q.-W. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase J. Biol. Chem. 269 1994 4705 4708
74. S.-W. Yu, S.A. Andrabi, H. Wang, N.S. Kim, G.G. Poirier, T.M. Dawson, and V.L. Dawson Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death Proc. Natl. Acad. Sci. USA 103 2006 18314 18319
75. S.W. Yu, H.M. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, G.G. Poirier, T.M. Dawson, and V.L. Dawson Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297 2002 259 263
76. W.X. Zong, D. Ditsworth, D.E. Bauer, Z.Q. Wang, and C.B. Thompson Alkylating DNA damage stimulates a regulated form of necrotic cell death Genes Dev. 18 2004 1272 1282